DGHO
The German, Austrian, and Swiss Societies for Hematology and Medical Oncology (DGHO) aims to share the latest advances in diagnosis and treatment across hematological and oncological conditions.
Click the links below to view further information about DGHO events and related resources on Medthority.
Managing High-Risk NMIBC
Expert and patient insights on high-risk NMIBC, including relevant clinical trial data and standout congress sessions.
Supportive Care in Oncology Learning Zone
Supportive care in oncology from a multidisciplinary team involves caring for patients with cancer, treatment adherence and adverse effect management.
CDK4/6 Inhibitors in Breast Cancer
Are you familiar with the clinical trial evidence that could help you to select the best cyclin dependent kinase 4/6 (CDK4/6) inhibitor for your metastatic breast cancer patient?
mCRPC in Focus
Unmet needs in the management of mCRPC, with a focus on treatments
PARP Inhibitor Selection in Ovarian Cancer Learning Zone
Up to date on the latest treatments for advanced ovarian cancer? Get expert insights and case studies on PARP inhibitors in ovarian cancer.
Future breast cancer care: ESMO Breast Cancer 2024
Congress coverage of ESMO Breast Cancer 2024, featuring the latest advances in research, treatment updates, expert interviews, and key takeaways.
Think Thrombosis
Latest data and clinical guidance
How do I register for DGHO events?
You can find information on upcoming and past events at the links further down this page. Can’t see next year’s event yet? Keep an eye out for information coming soon!